Spero Therapeutics Aktie
2,05
EUR
-0,21
EUR
-9,11
%
2,41
USD
-0,06
USD
-2,43
%
Werbung
Spero Therapeutics Aktie Analyse
| 09.02.18 | Spero Therapeutics Overweight | Cantor Fitzgerald | |
| 27.11.17 | Spero Therapeutics Outperform | Oppenheimer & Co. Inc. | |
| 27.11.17 | Spero Therapeutics Buy | Stifel, Nicolaus & Co., Inc. |
Werbung
Werbung